The 4 μL Sample Size is a Breakthrough

Doing more allergy tests with less sample benefits patients and labs. It seems like a little thing, but for pediatric patients, it’s really a big thing.

A NOVEOS™ System can run
10x more tests with the same
sample current systems use

  • Allergy profile typically has 10 - 35 tests per patient
     

  • Current Allergy instruments use 40 - 50 µL of sample  per specific IgE (sIgE) test
     

  • NOVEOS sIgE uses only 4 µL of serum per test
     

  • Reflex component allergen testing will exacerbate sample shortages (Quantity Not Sufficient, QNS)

Less sample per test improves the experience of patients and permits follow-up testing with fewer re-draws!

Benefits of avoiding
Quantity Not Sufficient
(QNS) Occurrences

  • Improving the patient experience while increasing management and testing efficiency
     

  • Errors occur with 2 – 10% of samples in allergy labs, and it’s more frequent in pediatric-focused labs.
     

  • QNS incidents cause an incomplete patient report, resulting in an incomplete picture for the clinician. 
     

  • Reduces the need for test prioritization by clinicians and laboratorians
     

  • Reduces the need for additional office visits which cause lost productivity
     

  • Reduces trauma for the patient and parent of a child of having another blood draw
     

  • Reduce the potential loss of revenue for the laboratory

“We try to perform all the requested tests while avoiding
the trauma of another venipuncture.” 

Lab, UK (1) 

1. Data on File. Pain Points Market Research,  May 2019.

Receive Notifications From HYCOR

  • LinkedIn

© 2020 HYCOR Biomedical  /  All Rights Reserved /  International Privacy  /  U.S Privacy  / info@hycorbiomedical.com